The clinical significance of Anti-Beta-1 adrenergic receptor autoantibodies in cardiac disease

Clinical Reviews in Allergy and Immunology

Volumn 44, Issue 1, 2013, Pages 75-83

  Nussinovitch, Udi ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti 1 adrenergic receptor autoantibodies; Arrhythmia; Autoimmunity; Chagas disease; Dilated cardiomyopathy; Ischemic cardiomyopathy

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR AUTOANTIBODY; IMMUNOGLOBULIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADVERSE OUTCOME; ANTIBODY RESPONSE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; FOLLOW UP; HEART DISEASE; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HUMAN; HUMORAL IMMUNITY; IMMUNOADSORPTION; IMMUNOTHERAPY; IN VITRO STUDY; ISCHEMIC CARDIOMYOPATHY; OXIDATIVE STRESS; PLASMAPHERESIS; QUALITY OF LIFE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; CHAGAS CARDIOMYOPATHY; HEART DISEASES; HUMANS; MYOCARDIAL ISCHEMIA; RECEPTORS, ADRENERGIC, BETA-1;

EID: 84872687795     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-010-8228-9     Document Type: Article

References (61)

1. Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7-14 (Pubitemid 44247194)
2. Nussinovitch U, Shoenfeld Y (2009) Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ther Exp 57:95-104
3. Brucato A, Maestroni S, Cumetti D et al (2008) Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 8:44-47
4. Gershwin ME (2008) The mosaic of autoimmunity. Autoimmun Rev 7:161-163
5. Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209-213
6. Gleicher N, Elkayam U (2009) Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev 8:384-387
7. Zifman E, Amital H, Gilburd B, Shoenfeld Y (2008) Antioxidants and smoking in autoimmune disease - opposing sides of the seesaw? Autoimmun Rev 8:165-169
8. Sitia S, Atzeni F, Sarzi-Puttini P et al (2009) Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev 8:281-286
9. Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 7:42-45 (Pubitemid 47633390)
10. Fritzler MJ (2008) Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 7:616-620
11. Briani C, Samaroo D, Alaedini A (2008) Celiac disease: from gluten to autoimmunity. Autoimmun Rev 7:644-650
12. Li Y, Heuser JS, Cunningham LC, Kosanke SD, Cunningham MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol 177:8234-8240 (Pubitemid 44846345)
13. Bizzaro N (2007) Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev 6:325-333 (Pubitemid 46810400)
14. Jahns R, Boivin V, Hein L et al (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest 113:1419-1429 (Pubitemid 39071697)
15. Sterin-Borda L, Cossio PM, Gimeno MF et al (1976) Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects. Cardiovasc Res 10:613-622
16. Yoshikawa T, Baba A, Nagatomo Y (2009) Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 73:602-607
17. Jane-wit D, Altuntas CZ, Johnson JM et al (2007) Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 116:399-410 (Pubitemid 47196545)
18. Nikolaev VO, Boivin V, Stork S et al (2007) A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure. J Am Coll Cardiol 50:423-431 (Pubitemid 47088126)
19. Chiale PA, Ferrari I, Mahler E et al (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103:1765-1771 (Pubitemid 32291414)
20. Nagatomo Y, Yoshikawa T, Kohno T et al (2009) A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 15:224-232
21. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 36:1280-1287
22. Freedman NJ, Lefkowitz RJ (2004) Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation. J Clin Invest 113:1379-1382 (Pubitemid 39071690)
23. Tutor AS, Penela P, Mayor F Jr (2007) Anti-beta1-adrenergic receptor autoantibodies are potent stimulators of the ERK1/2 pathway in cardiac cells. Cardiovasc Res 76:51-60 (Pubitemid 47362039)
24. Hebert TE (2007) Anti-beta1AR antibodies in dilated cardiomyopathy: are these a new class of receptor agonists? Cardiovasc Res 76:5-7 (Pubitemid 47371118)
25. Nussinovitch U, Katz U, Nussinovitch M, Blieden L, Nussinovitch N (2009) Echocardiographic abnormalities in familial dysautonomia. Pediatr Cardiol 30:1068-1074
26. Stork S, Boivin V, Horf R et al (2006) Stimulating autoantibodies directed against the cardiac beta1-adrenergic receptor predict increased mortality in idiopathic cardiomyopathy. Am Heart J 152:697-704 (Pubitemid 44396891)
27. Christ T, Wettwer E, Dobrev D et al (2001) Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33:1515-1525 (Pubitemid 32681669)
28. Medei EH, Nascimento JH, Pedrosa RC et al (2008) Antibodies with beta-adrenergic activity from chronic chagasic patients modulate the QT interval and M cell action potential duration. Europace 10:868-876 (Pubitemid 351882074)
29. Nussinovitch N, Livneh A, Katz K et al (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353-1356
30. Iwata M, Yoshikawa T, Baba A, Anzai T, Mitamura H, Ogawa S (2001) Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 37:418-424
31. Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7:445-452
32. Staudt Y, Mobini R, Fu M, Felix SB, Kuhn JP, Staudt A (2003) Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 466:1-6 (Pubitemid 36385084)
33. Wallukat G, Muller J, Hetzer R (2002) Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:1806 (Pubitemid 35375628)
34. Caforio AL, Tona F, Bottaro S et al (2008) Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy. Autoimmunity 41:35-45
35. Mobini R, Staudt A, Felix SB et al (2003) Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathy. J Autoimmun 20:345-350 (Pubitemid 36677526)
36. Muller J, Wallukat G, Dandel M et al (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385-391 (Pubitemid 30067394)
37. Gao Y, Liu HR, Zhao RR, Zhi JM (2006) Autoantibody against cardiac beta1-adrenoceptor induces apoptosis in cultured neonatal rat cardiomyocytes. Acta Biochim Biophys Sin 38:443-449 (Pubitemid 44091735)
38. Mao W, Fukuoka S, Iwai C et al (2007) Cardiomyocyte apoptosis in autoimmune cardiomyopathy: mediated via endoplasmic reticulum stress and exaggerated by norepinephrine. Am J Physiol Heart Circ Physiol 293:H1636-1645 (Pubitemid 47367210)
39. Liang CS, Mao W, Liu J (2008) Pro-apoptotic effects of anti-beta1-adrenergic receptor antibodies in cultured rat cardiomyocytes: actions on endoplasmic reticulum and the prosurvival PI3K-Akt pathway. Autoimmunity 41:434-441
40. Nussinovitch U, Shoenfeld Y (2010) Anti-troponin autoantibodies and the cardiovascular system. Heart 96:1518-1524
41. Chiale PA, Garro HA, Schmidberg J et al (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta adrenergic receptors. Heart Rhythm 3:1182-1186 (Pubitemid 44464147)
42. Magnusson Y, Marullo S, Hoyer S et al (1990) Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest 86:1658-1663 (Pubitemid 20372617)
43. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML (1999) Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29:43-51 (Pubitemid 29097571)
44. Jahns R, Boivin V, Siegmund C, Boege F, Lohse MJ, Inselmann G (1999) Activating beta-1-adrenoceptor antibodies are not associated with cardiomyopathies secondary to valvular or hypertensive heart disease. J Am Coll Cardiol 34:1545-1551 (Pubitemid 29528670)
45. Nishikubo K, Imanaka-Yoshida K, Tamaki S et al (2007) Th1-type immune responses by Toll-like receptor 4 signaling are required for the development of myocarditis in mice with BCG-induced myocarditis. J Autoimmun 29:146-153 (Pubitemid 47385115)
46. Li HS, Ligons DL, Rose NR (2008) Genetic complexity of autoimmune myocarditis. Autoimmun Rev 7:168-173
47. Nussinovitch U, Shoenfeld Y (2008) Autoimmune dilated cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic criteria in autoimmune diseases. The Humana Press Inc, New Jersey, USA, pp 367-372
48. Lazzerini PE, Capecchi PL, Guideri F et al (2008) Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 103:1-11 (Pubitemid 50002797)
49. Aso S, Yazaki Y, Kasai H et al (2009) Anti-beta 1-adrenoreceptor autoantibodies and myocardial sympathetic nerve activity in chronic heart failure. Int J Cardiol 131:240-245
50. Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM (2006) Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease. Microbes Infect 8:2459-2464 (Pubitemid 44515149)
51. Mahler E, Sepulveda P, Jeannequin O et al (2001) A monoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor. Eur J Immunol 31:2210-2216 (Pubitemid 32640738)
52. Labovsky V, Smulski CR, Gomez K, Levy G, Levin MJ (2007) Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. Clin Exp Immunol 148:440-449 (Pubitemid 46701041)
53. Kivity, S.; Katz, U.; Daniel, N.; Nussinovitch, U.; Papageorgiou, N.; Shoenfeld, Y. (2009) Evidence for the use of intravenous immunoglobulins-a review of the literature. Clin Rev Allergy Immunol 38:201-269
54. Schimke I, Muller J, Dandel M et al (2005) Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study. J Clin Apher 20:137-142 (Pubitemid 43081861)
55. Staudt A, Bohm M, Knebel F et al (2002) Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 106:2448-2453 (Pubitemid 35278800)
56. Baba A, Akaishi M, Shimada M et al (2010) Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure. Circ J 74:1372-1378
57. Matsui S, Larsson L, Hayase M et al (2006) Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function. J Mol Cell Cardiol 41:78-85 (Pubitemid 43964935)
58. Ruffatti A, Marson P, Pengo V et al (2007) Plasma exchange in the management of high risk pregnant patients with primary antiphospholipid syndrome. A report of 9 cases and a review of the literature. Autoimmun Rev 6:196-202 (Pubitemid 46187339)
59. Gesinde MO, Tan LB, Gooi HC (2007) Plasma exchange treatment to reduce anti-beta1-adrenergic receptor antibody in a patient with dilated cardiomyopathy. J Clin Apher 22:241-242 (Pubitemid 47320239)
60. Miao GB, Liu JC, Liu MB et al (2006) Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment. Eur J Clin Investig 36:614-620 (Pubitemid 44213827)
61. Levin MJ, Hoebeke J (2008) Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease. Autoimmunity 41:429-433